Susumu Eguchi | Medicine and Dentistry | Best Researcher Award

Prof. Susumu Eguchi | Medicine and Dentistry | Best Researcher Award

Professor and Chairman from Nagasaki University Graduate School of Biomedical Sciences, Japan

Dr. Susumu Eguchi, M.D., Ph.D., F.A.C.S., F.E.B.S., is a globally recognized expert in the field of liver transplantation, hepatobiliary (HPB) surgery, and regenerative medicine. As a Professor and Chairman at the Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Dr. Eguchi has demonstrated outstanding leadership in both clinical and academic arenas. His medical journey is marked by international exposure, significant research contributions, and a wide array of prestigious editorial appointments. He has actively shaped the advancement of liver surgery, particularly focusing on liver regeneration and hepatocyte-based therapies. Dr. Eguchi’s dedication extends beyond national boundaries, with ongoing collaborations as a visiting professor in China and Kazakhstan, strengthening cross-cultural medical education and research. His active participation in hospital management, international medical center leadership, and nuclear disaster preparedness showcases his multifaceted expertise. Additionally, his editorial influence in several leading surgical and transplantation journals underlines his authority and commitment to knowledge dissemination. Throughout his distinguished career, Dr. Eguchi has significantly contributed to the global medical community and is highly regarded for his ability to combine innovative research with practical surgical excellence. His holistic approach and deep impact in the field make him a prominent figure deserving international recognition.

Professional Profile

Education

Dr. Susumu Eguchi’s educational journey is marked by rigorous academic training and international exposure that shaped his expertise in surgery and transplantation. He graduated from the Nagasaki University School of Medicine in 1992, where he developed a solid foundation in medical sciences. His dedication to deepening his knowledge led him to pursue a Ph.D. at the Nagasaki University Graduate School of Biomedical Sciences, Department of Surgery, from April 1994 to March 1998. This doctoral program was pivotal in advancing his surgical and research competencies, particularly in the hepatobiliary and liver transplantation domains. His international perspective was further broadened during his time at Cedars-Sinai Medical Center in the United States from 1994 to 1997, where he gained valuable experience in surgical research. Dr. Eguchi’s education provided him with a comprehensive blend of clinical, academic, and research-based learning that later translated into his significant contributions to the surgical field. The integration of both Japanese and Western medical training environments equipped him with a unique ability to lead innovative research and clinical practices. His academic progression reflects a consistent pursuit of excellence and positioned him to become an influential leader in liver transplantation and regenerative medicine.

Professional Experience

Dr. Susumu Eguchi has an extensive and distinguished professional career spanning over three decades, characterized by leadership roles in clinical practice, international collaborations, and academic governance. His journey began as a surgical trainee at Nagasaki University Hospital, and he further honed his skills at Cedars-Sinai Medical Center, focusing on surgical research. He has served in key positions such as Chief of Surgery at various hospitals, including National Tsushima Hospital and Nakatsushima Hospital. His international clinical fellowship at Groningen University Hospital in the Netherlands specialized in liver transplantation and hepatobiliary surgery, deepening his expertise in these fields. Since 2012, he has been a Professor at Nagasaki University Graduate School of Biomedical Sciences, where he also took on administrative roles, including Deputy Hospital Director and Director of the International Medical Center and Transplant Center. His global influence is evident through his visiting professorship at Guangzhou First Municipal People’s Hospital and Professor Emeritus roles at prestigious institutions in Kazakhstan and China. Dr. Eguchi’s career reflects a perfect balance of surgical excellence, academic leadership, and international outreach. His continuous involvement in both patient care and research highlights his dedication to advancing surgical techniques and improving patient outcomes globally.

Research Interest

Dr. Susumu Eguchi’s research interests are centered around advancing liver transplantation, hepatobiliary surgery, liver regeneration, and regenerative medicine. His work has significantly contributed to the development of liver surgery techniques and the enhancement of liver transplantation outcomes. A major focus of his research involves hepatocyte-based therapy, exploring the potential of regenerative treatments to restore liver function and improve long-term survival rates for patients. Dr. Eguchi is also deeply invested in liver regeneration studies, aiming to unravel cellular and molecular mechanisms that can accelerate or support liver recovery after surgery or damage. His commitment to hepatobiliary and pancreatic (HPB) surgery research integrates both clinical advancements and innovative therapies, addressing complex surgical challenges. Additionally, Dr. Eguchi has shown interest in disaster response and medical preparedness, applying his medical leadership to nuclear disaster situations. His broad research spectrum allows him to contribute to multidisciplinary fields, including surgical innovation, organ preservation, and post-operative recovery strategies. With his global perspective and cross-institutional collaborations, Dr. Eguchi continues to drive progress in improving surgical outcomes and patient care. His pioneering research offers promising solutions in regenerative medicine and solid organ transplantation, pushing the boundaries of modern surgical practices.

Research Skills

Dr. Susumu Eguchi possesses a wide range of research skills that reflect his technical mastery and innovative approach in the field of surgery and transplantation. He is highly skilled in complex liver surgery, hepatobiliary surgical techniques, and organ transplantation procedures. His research capabilities encompass hepatocyte-based therapy development, liver regeneration studies, and regenerative medicine applications. Dr. Eguchi is adept at designing clinical trials, managing multi-institutional research projects, and applying translational research principles to bridge laboratory findings with patient care improvements. His leadership in surgical research has been recognized internationally, contributing to advancements in both surgical methodologies and post-operative patient management. Moreover, Dr. Eguchi demonstrates strong skills in cross-cultural medical collaboration, contributing to the development of global treatment standards. His editorial roles across multiple high-impact journals also indicate his proficiency in critical peer review, scientific writing, and knowledge dissemination. He is experienced in guiding surgical teams, mentoring young researchers, and overseeing international research initiatives. Additionally, his involvement in disaster preparedness reflects his ability to integrate surgical expertise with public health strategies. Dr. Eguchi’s exceptional surgical and research skills collectively position him as a leading figure in the evolution of liver surgery and transplantation.

Awards and Honors

Dr. Susumu Eguchi has received numerous prestigious certifications and honors throughout his distinguished career, which underline his excellence and global recognition in the surgical community. He is a Fellow of the American College of Surgeons (F.A.C.S.), a Fellow of the European Board of Surgery (F.E.B.S.), a Fellow of the International College of Surgeons (F.I.C.S.), and has been recognized as an IASGO Fellow (FASGO) since 2023. His leadership and contributions have earned him honorary titles, such as Professor Emeritus at both Syzganovs’ National Scientific Centre of Surgery in Kazakhstan and The Second Affiliated Hospital to Nanchang University in China. Dr. Eguchi’s exceptional academic contributions are further demonstrated through his numerous editorial appointments in influential journals, including Transplantation, SURGERY, Hepatology Research, Journal of Hepato-Biliary-Pancreatic Science, and Annals of Gastroenterological Surgery. His editorial influence reflects his standing as an expert in the field and his commitment to advancing global surgical knowledge. These accolades not only validate his exceptional skills and research contributions but also emphasize his role as an international leader and innovator in liver transplantation and hepatobiliary surgery.

Conclusion

In conclusion, Dr. Susumu Eguchi is an outstanding and highly accomplished surgeon, educator, and researcher whose contributions to the fields of liver transplantation, hepatobiliary surgery, and regenerative medicine have had a profound impact both in Japan and internationally. His career is marked by an exceptional blend of clinical excellence, academic leadership, and global collaboration. Dr. Eguchi’s extensive research into liver regeneration and hepatocyte-based therapy offers significant advancements in surgical techniques and patient care. His ability to successfully bridge international academic relationships, lead hospital departments, and manage disaster preparedness initiatives highlights his multifaceted expertise. His prestigious fellowships, editorial leadership roles, and international professorships further attest to his global influence and professional recognition. Although future efforts to showcase quantitative research impact, such as citation metrics, could further solidify his academic profile, his achievements to date are exemplary. Dr. Eguchi continues to inspire the next generation of surgeons and researchers through his innovative work, extensive mentorship, and dedication to improving liver surgery outcomes worldwide. Based on his contributions and leadership, he is an exceptional candidate for recognition as a leading researcher and an ideal recipient of the Best Researcher Award.

Publications Top Notes

1. Transplantation of chemically induced liver progenitors in Nagase analbuminemic rats under liver regenerative stimulus

Authors: Masayuki Fukumoto, Akihiko Soyama, Daisuke Miyamoto, Takanobu Hara, Hajime Matsushima, Hajime Imamura, Mampei Yamashita, Tomohiko Adachi, Kengo Kanetaka, Susumu Eguchi
Year: 2025

2. Association Between Distance to the Transplant Center and Survival Following Living Donor Liver Transplantation

Authors: Hajime Matsushima, Akihiko Soyama, Takanobu Hara, Ayaka Kinoshita, Takashi Hamada, Kazushige Migita, Ayaka Satoh, Hajime Imamura, Tomohiko Adachi, Susumu Eguchi
Year: 2025

3. Effect on short‐term outcomes of the COVID‐19 pandemic following laparoscopic distal gastrectomy and low anterior resection for gastric and rectal cancer: A retrospective study using the Japanese National Clinical Database, 2018–2022

Authors: Masafumi Inomata, Hideki Endo, Tomonori Akagi, Hidefumi Shiroshita, Shigeki Yamaguchi, Susumu Eguchi, Norihito Wada, Yukinori Kurokawa, Yosuke Seki, Yoshiharu Sakai, et al.
Year: 2025

4. Limitations of the proposed lymph node classification in intrahepatic cholangiocarcinoma

Author: Susumu Eguchi
Year: 2025

5. Annual report on National Clinical Database 2021 for gastroenterological surgery in Japan

Authors: Sunao Ito, Arata Takahashi, Hideki Ueno, Shuji Takiguchi, Yoshiki Kajiwara, Yoshihiro Kakeji, Susumu Eguchi, Takanori Goi, Akio Saiura, Akira Sasaki, et al.
Year: 2025

6. Histopathological Downgrading of Borderline Phyllodes Tumor in a Young Patient Following Chemotherapy: A Case Report

Authors: Yuki Hara, Rin Yamaguchi, Ryota Otsubo, Ayako Fukushima, Eiko Inamasu, Momoko Akashi, Michi Morita, Sayaka Kuba, Susumu Eguchi, Keitaro Matsumoto
Year: 2024

7. Efficacy of chemically induced human hepatic progenitor cells from diseased liver against nonalcoholic steatohepatitis model

Authors: Daisuke Miyamoto, Kunihito Matsuguma, Kazuhiro Nagai, Takayuki Miyoshi, Takanobu Hara, Hajime Matsushima, Akihiko Soyama, Takahiro Ochiya, Yasushi Miyazaki, Susumu Eguchi
Year: 2024

8. Current status and future perspectives of robotic liver surgery

Authors: Akihiko Soyama, Takashi Hamada, Tomohiko Adachi, Susumu Eguchi
Year: 2024

9. Essential updates 2022/2023: A review of current topics in robotic hepatectomy

Authors: Tomohiko Adachi, Takanobu Hara, Hajime Matsushima, Akihiko Soyama, Susumu Eguchi
Year: 2024

10. Short‐term outcomes after liver resection with vascular reconstruction: Results from a study with the National Clinical Database of Japan

Authors: Akihiko Soyama, Hiroyuki Yamamoto, Susumu Eguchi, Atsushi Nanashima, Yoshihiro Kakeji, Yuko Kitagawa, Masafumi Nakamura, Itaru Endo
Year: 2024

Jiaqi Zhang | Medicine and Dentistry | Best Researcher Award

Dr. Jiaqi Zhang | Medicine and Dentistry | Best Researcher Award

Chief resident from Peking University Third Hospital, China

Dr. Jiaqi Zhang is currently serving as Chief Resident in the Department of Orthopedics at Peking University Third Hospital. A dedicated medical professional and clinical researcher, he has established a specialized focus on spinal deformities in adults, particularly those of complex and congenital origins. With a medical degree in orthopedics from the prestigious Peking University, Dr. Zhang integrates clinical expertise with rigorous research activities. He is also actively involved in academic research as part of the Beijing Key Laboratory of Spinal Disease Research and the Engineering Research Center of Bone and Joint Precision Medicine, affiliated with China’s Ministry of Education. Dr. Zhang has contributed to peer-reviewed literature, with five published articles in SCI-indexed journals that delve into advanced diagnostic imaging and surgical outcomes. His most notable contribution lies in identifying MRI indicators for poor prognosis in patients with congenital angular kyphosis, which has practical implications in spine surgery decision-making. Though early in his research career, Dr. Zhang is committed to advancing orthopedic science and improving patient care outcomes. He continues to develop his expertise through ongoing clinical research projects and aims to expand his impact through collaborative studies and innovation in spinal surgery.

Professional Profile

Education

Dr. Jiaqi Zhang earned his Doctor of Orthopedics degree from Peking University, one of China’s most esteemed medical institutions. His education laid a robust foundation in both theoretical and practical aspects of orthopedic surgery, with a growing focus on spinal deformities during his residency years. The program provided intensive clinical training combined with exposure to academic research, enabling him to understand the intricacies of musculoskeletal disorders at both clinical and cellular levels. In addition to his core medical training, Dr. Zhang engaged in independent studies and mentored research activities that emphasized evidence-based medicine, biomechanics, and diagnostic imaging. His thesis work and research outputs during the doctoral program reflected a deep interest in the surgical management of complex spinal conditions, an area which would later become his primary research focus. Peking University’s commitment to academic excellence, interdisciplinary research, and advanced medical technologies has played a crucial role in shaping Dr. Zhang’s clinical acumen and investigative mindset. The educational environment also allowed him to build competencies in surgical planning, patient care management, and ethical clinical research, positioning him to serve effectively in both hospital and academic settings.

Professional Experience

Dr. Jiaqi Zhang currently holds the position of Chief Resident in the Department of Orthopedics at Peking University Third Hospital, a leading medical institution in China. In this capacity, he manages a wide array of clinical responsibilities, ranging from patient diagnosis and pre-operative evaluations to complex spinal surgeries and post-operative care. His role demands a high degree of precision, leadership, and the ability to make swift, informed decisions in high-pressure environments. In parallel with his clinical duties, Dr. Zhang also serves as a researcher in the Beijing Key Laboratory of Spinal Disease Research and the Engineering Research Center of Bone and Joint Precision Medicine. These appointments allow him to participate in translational research efforts focused on improving the treatment and understanding of spinal disorders. Through these roles, Dr. Zhang has been actively involved in three major clinical research projects, integrating data analysis, surgical innovation, and radiological evaluation. His clinical insights feed directly into his research questions, creating a dynamic loop between patient care and scientific discovery. Although still in the early stages of his career, Dr. Zhang has demonstrated professional maturity and a strong commitment to interdisciplinary collaboration in both clinical and academic spheres.

Research Interests

Dr. Jiaqi Zhang’s research interests are centered around the surgical treatment and pathophysiological mechanisms of adult spinal deformity, with a specialized focus on rare and complex conditions such as congenital angular kyphosis. He is particularly interested in the intersection of diagnostic imaging and surgical outcomes, seeking to improve preoperative planning through advanced radiological markers. One of his primary research goals is to develop predictive models based on MRI indicators to identify patients at higher risk of poor neurological recovery. His study of compressive myelopathy associated with severe kyphosis is a reflection of this interest, where he demonstrated the value of quantifying MRI features such as T1WI hypointensity and MTAC ratios. Dr. Zhang also aims to explore how early surgical intervention can prevent irreversible spinal cord damage, with implications for refining surgical timing and techniques. His broader interests include spinal biomechanics, spinal cord injury recovery, and minimally invasive surgical innovations. Through evidence-based practice and rigorous analysis, he aspires to contribute to the development of clinical guidelines that enhance surgical decision-making and long-term patient outcomes. Future research plans include collaborating with biomedical engineers and radiologists to explore imaging-based AI models in spine surgery.

Research Skills

Dr. Jiaqi Zhang possesses a comprehensive set of research skills that complement his clinical expertise in orthopedic surgery. He is proficient in clinical research design, patient data analysis, and statistical interpretation, particularly in relation to outcome-based studies in spinal surgery. His methodological skills are reflected in his rigorous screening of patient cohorts and meticulous evaluation of radiological parameters, such as those used in his study on congenital angular kyphosis and myelopathy. He has hands-on experience with MRI data analysis and its integration into surgical planning, which enhances both predictive and outcome assessment models. Dr. Zhang is also familiar with scientific writing, literature review methodologies, and the publication process, as evidenced by his five publications in peer-reviewed, SCI-indexed journals. While he has yet to engage in industry collaborations or patent development, he shows potential to expand his research competencies through interdisciplinary projects. Additionally, he is comfortable working with medical imaging software and clinical databases, enabling him to bridge diagnostic tools with surgical interventions. His commitment to ethical standards in clinical research and informed consent processes further strengthens his skill set. As he continues his academic and clinical journey, Dr. Zhang aims to refine his skills in grant writing, protocol development, and advanced statistical tools.

Awards and Honors

As of the current application, Dr. Jiaqi Zhang has not listed any formal awards or honors. However, his selection as Chief Resident at Peking University Third Hospital is itself indicative of his academic and professional excellence. Chief residency is typically awarded to individuals who have demonstrated exceptional clinical skills, leadership capabilities, and research promise during their training. Additionally, his role as a researcher in the Beijing Key Laboratory of Spinal Disease Research and the Engineering Research Center of Bone and Joint Precision Medicine reflects institutional recognition of his potential to contribute meaningfully to high-impact research. While he may not yet have received formal accolades such as national awards or fellowships, Dr. Zhang is on a promising trajectory. His recent publications, innovative work in MRI-based surgical prognosis, and growing presence in peer-reviewed literature may soon garner greater professional recognition. As he continues to expand his academic portfolio through additional publications, collaborative projects, and advanced studies, he is likely to become a strong candidate for future awards and honors in both national and international orthopedic research communities.

Conclusion

Dr. Jiaqi Zhang is a dedicated clinician-researcher who exemplifies a balanced integration of academic rigor and clinical acumen. His research, though still in early stages, targets a highly specialized and clinically significant area—adult spinal deformity with neurologic complications. The outcomes of his studies provide practical guidance for surgeons in managing complex cases, particularly through the use of MRI-based prognostic markers. While his profile would benefit from broader research collaborations, industry partnerships, and increased visibility through awards or society memberships, his current contributions lay a strong foundation for future growth. With five SCI-indexed publications, three active research projects, and a leadership role as Chief Resident, Dr. Zhang has demonstrated a consistent commitment to advancing orthopedic science. His ability to translate clinical challenges into research questions, coupled with his skill in data-driven analysis, positions him as a rising contributor to the field of spinal surgery. In conclusion, Dr. Jiaqi Zhang has the potential to become a leading voice in orthopedic research, provided he continues to build on his current achievements with expanded collaborations and continued innovation.

Mohamed Balata | Medicine and Dentistry | Best Researcher Award

Assist. Prof. Dr. Mohamed Balata | Medicine and Dentistry | Best Researcher Award

Mansoura University hospital, Egypt

Dr. Mohamed Balata is a dedicated and accomplished Egyptian general and colorectal surgeon affiliated with Mansoura University Hospital, Egypt. With a robust academic background and extensive clinical training, Dr. Balata has built a reputation in both surgical practice and academic teaching. His clinical interests primarily revolve around laparoscopic and minimally invasive colorectal surgeries, as well as emerging techniques in bariatric and laser-assisted procedures. Over the past decade, he has developed advanced surgical skills and contributed to significant peer-reviewed publications, reflecting a balance between academic research and clinical excellence. Dr. Balata currently serves as a Consultant and Lecturer at the Faculty of Medicine, Mansoura University, where he is actively involved in training medical students and residents. His contributions to international scientific literature and his award-winning research on rectocele repair underscore his commitment to evidence-based surgery. Known for his expertise in managing complex surgical cases and for his continuous participation in workshops and professional development courses, Dr. Balata demonstrates strong leadership in surgical education and innovation. His collaborative spirit, excellent communication skills, and drive for clinical research position him as a distinguished professional within the field of surgery, particularly in colorectal procedures and functional outcomes.

Professional Profile

Education

Dr. Mohamed Balata possesses a well-rounded educational background in general and colorectal surgery, obtained from one of Egypt’s leading medical institutions—Mansoura University. He earned his MD in General Surgery in December 2019, following a Master’s degree in the same specialty in September 2014. His academic journey began with obtaining a medical license from the Ministry of Health and Population in March 2011, which marked the formal start of his clinical career. Notably, in November 2009, he completed an MD Degree in General and Colorectal Surgery with an Excellent with Honors grade from the Faculty of Medicine, Mansoura University. This early academic distinction laid the foundation for a career steeped in clinical rigor and academic excellence. Dr. Balata’s education has been supplemented by his participation in numerous professional development workshops and certified training programs, including international publication courses and advanced laparoscopic surgery sessions. His continuous educational efforts reflect a commitment to lifelong learning and adapting to evolving surgical technologies. This foundation has enabled him to effectively translate theoretical knowledge into practical surgical proficiency and has paved the way for his progression into roles of higher academic and clinical responsibility.

Professional Experience

Dr. Mohamed Balata has accumulated over a decade of progressive clinical and academic experience in general and colorectal surgery. He currently serves as a Consultant and Lecturer at the General Surgery Department of Mansoura University Hospital, a position he has held since January 2020. His prior roles include Assistant Lecturer (2014–2020) and Teaching Assistant (2014) at the same institution. These academic appointments are complemented by his earlier clinical work, including his tenure as a Specialist of General Surgery at the Health Affairs Directorate under Egypt’s Ministry of Health. His surgical residency from 2011 to 2014 at Mansoura University Hospitals provided foundational experience in managing a diverse range of general surgical cases. Dr. Balata’s career also includes roles as a General Practitioner and completion of an internship year at Mansoura University Hospitals. Throughout these roles, he has not only refined his surgical skills but also demonstrated dedication to medical education by actively engaging in training medical students, surgical residents, and board-certified doctors. His teaching contributions, coupled with advanced clinical practice, reflect a strong dual commitment to both patient care and academic medicine, making him a well-rounded professional in the medical and surgical community.

Research Interest

Dr. Mohamed Balata’s research interests lie primarily in general and colorectal surgery, with a focused emphasis on minimally invasive and functional outcomes of surgical interventions. His work investigates the comparative effectiveness of various surgical approaches, including laparoscopic versus open procedures, and their impact on postoperative recovery and quality of life. One of his notable research contributions explored the functional and sexual quality of life following transperineal versus transvaginal repair of anterior rectocele, which was recognized internationally. Additionally, he has shown keen interest in stem cell applications for anal sphincter repair, manometric assessments in rectocele management, and innovations in pilonidal disease treatments, including laser techniques. Dr. Balata’s scholarly output reflects a clinical-research integration, where surgical decision-making is informed by empirical findings. His multidisciplinary approach includes collaboration with gastroenterology, gynecology, and radiology departments to deliver holistic patient care. He also explores surgical education and skill development through observational studies and clinical trials. His research not only advances surgical protocols but also contributes to academic literature and evidence-based guidelines, especially within the field of functional colorectal disorders. Dr. Balata remains committed to expanding this portfolio, aiming to improve patient outcomes and enhance surgical standards regionally and globally.

Research Skills

Dr. Mohamed Balata is equipped with a comprehensive suite of research skills that align with his clinical expertise in general and colorectal surgery. He has hands-on experience in designing and executing clinical trials, as evidenced by his randomized controlled study on rectocele repair outcomes. His methodological competencies include data analysis using SPSS and Stata, literature reviews, and manuscript preparation for peer-reviewed journals. Dr. Balata is well-versed in both qualitative and quantitative research techniques and is proficient in international scientific publishing. He has collaborated with interdisciplinary teams to explore various aspects of surgical innovation and patient care. His familiarity with ethical standards and research protocols ensures compliance in human subject research. Additionally, he possesses strong presentation and communication skills, having participated in international conferences and surgical workshops. He has the capability to translate complex clinical findings into practical applications, a trait that enhances his teaching and mentorship roles. Furthermore, his work in observational studies, surgical outcome measures, and patient quality of life assessments demonstrates a strong understanding of clinical research metrics. These research skills not only support his academic publications but also enable him to contribute meaningfully to evidence-based surgical practice and policy-making.

Awards and Honors

Dr. Mohamed Balata has received notable recognition for his contributions to surgical research and clinical excellence. Most prominently, he was awarded for the Best Publication by the American Society of Colon and Rectal Surgeons (ASCRS) in 2020. This prestigious accolade was granted for his study titled “Functional outcome and Sexual-Related Quality of Life after Transperineal versus Transvaginal Repair of Anterior Rectocele,” which was published in the Diseases of the Colon & Rectum journal. The award highlights not only the academic merit of his work but also its clinical relevance in advancing surgical practice. In addition to international recognition, Dr. Balata has consistently demonstrated academic excellence from his early education, including graduating with honors. His research continues to attract attention for its innovative approaches and direct impact on improving patient outcomes. These honors underscore his dedication to blending surgical expertise with rigorous academic inquiry. Furthermore, his active membership in the Egyptian Society of Surgeons and the Egyptian Group of Colorectal Surgeons positions him within key professional networks that support ongoing learning and recognition. These achievements validate Dr. Balata’s standing as a committed and impactful researcher in the medical and surgical fields.

Conclusion

Dr. Mohamed Balata stands out as a highly competent and research-driven colorectal surgeon who has successfully integrated clinical practice with academic scholarship. His robust educational foundation, combined with his professional experience in one of Egypt’s leading medical institutions, reflects both depth and breadth of expertise. Through his internationally recognized research, he has addressed critical aspects of surgical outcomes, quality of life, and minimally invasive techniques. His ability to conduct, publish, and present high-quality research underscores his capacity for independent investigation and scientific communication. Furthermore, Dr. Balata’s contributions as a lecturer and mentor indicate a commitment to shaping the next generation of surgeons. He consistently pursues academic excellence through workshops, professional society memberships, and participation in national and international forums. While his current achievements are substantial, opportunities for further interdisciplinary collaboration and grant acquisition could expand the reach and application of his work. In summary, Dr. Balata is a well-rounded academic surgeon who meets the criteria for the Best Researcher Award through his strong publication record, commitment to clinical innovation, and active involvement in surgical education and research. His profile exemplifies excellence in translational surgical science and continuous professional development.

Publications Top Notes

  1. Title: Outcomes of Concomitant Laparoscopic Sleeve Gastrectomy and Hiatal Hernia Repair on Gastroesophageal Reflux Disease in Patients with Severe Obesity: A Propensity Score-Matched Analysis

  2. Authors: El Nakeeb, Ayman M.; Aldossary, Hassan Maged; Zaid, Ahmed; Alnakeeb, Kareem; Attia, Mohamed Sabry

  3. Journal: Obesity Surgery: Including Laparoscopy and Allied Care

  4. Year: 2025

 

Qingyuan Zhang | Medical Oncology | Best Researcher Award

Prof. Qingyuan Zhang | Medical Oncology | Best Researcher Award

Harbin Medical University Cancer Hospital, china

Dr. Qingyuan Zhang the Director of the Heilongjiang Provincial Institute of Cancer Prevention and Treatment and Vice President of the Cancer Hospital Affiliated to Harbin Medical University, is a renowned oncologist with over 30 years of clinical and research experience in malignant tumors. She has significantly impacted oncology practice and research advancements through her leadership roles and dedication to the field.

Professional Profile

Education

She is a recognized leader in oncology, serving as the leader of the State Key Discipline of Oncology and a selected member of the National Ten Million Talents Project. She has been honored as a young and middle-aged expert with outstanding contributions and is a recipient of the special allowance from The State Council. Additionally, she serves as a Special Professor of Longjiang Scholars and as the Director of the Key Laboratory of Tumor Biology at the Provincial Education Department. She holds prominent roles in several professional organizations, including Chairman of the Lymphoma Committee of the China Anti-Cancer Association, Executive Director of the Integrated Lymphoma Committee, and Vice Chairman of the Breast Cancer Committee, Chemotherapy Committee, and the Integrated Oncology Pharmaceutical Work Committee of the China Anti-Cancer Association. She is also a Standing Member of the Cancer Rehabilitation and Palliative Care Committee and serves as Vice Chairman of the Breast Cancer Expert Committee of the Chinese Society of Clinical Oncology, in addition to holding leadership positions in provincial oncology associations

Clinical Expertise

Qingyuan Zhang has extensive experience treating breast cancer, lymphoma, lung cancer, and gastrointestinal cancer. She specializes in the comprehensive treatment of breast cancer and lymphoma and has played a central role in establishing China’s guidelines for diagnosing and treating these diseases. Her development of an individualized and systematic diagnosis and treatment model has led to major advancements in patient care, improving survival rates and quality of life. Dr. [Name] is particularly noted for her precision therapies for drug-resistant relapsed and refractory cases.

Research Achievements

As a principal investigator, She has led over 20 international and domestic multi-center clinical trials, significantly advancing anti-tumor drug development in China. Her research contributions have been supported by:

  • Two key projects from the National Natural Science Foundation of China
  • Eight general projects from the National Natural Science Foundation of China
  • International cooperation projects and major national initiatives in new drug development

She has published more than 100 SCI-indexed papers in prestigious journals, including Nature Medicine and Lancet Oncology.

Awards and Academic Contributions

Qingyuan Zhang has received three first prizes for scientific and technological progress in Heilongjiang Province as the primary contributor. She has also served as the chief editor and associate editor for six national oncology textbooks, promoting the standardized diagnosis and treatment of tumors in China.

Publication Top Notes

  • Intravenous liposomal irinotecan in metastatic triple-negative breast cancer after ≥ 2 prior lines of chemotherapy: a phase Ib study”
    • Authors: Fan, Y., Zhang, Q., Yan, M., Zhao, X., Xu, B.
    • Year: 2025
    • Journal: Nature Communications
    • Volume: 16
    • Issue: 1
    • Page: 3
    • DOI: 10.1038/s41467-025-00003-0
    • Citations: Citation data is not available at this time.
  • “Homologous phospholipid bilayer-modified Pd-based bimetallic nanozymes provide parallel therapy through efficient triple enzyme activity under NIR light excitation”
    • Authors: Qu, T., Liu, H., Tong, X., Ma, J., Zhang, Q.
    • Year: 2025
    • Journal: Nature Communications
    • Volume: 16
    • Issue: 1
    • Page: 4
    • DOI: 10.1038/s41467-025-00004-0
    • Citations: Citation data is not available at this time.
  • “Pharmacokinetics, efficacy, and safety of subcutaneous versus intravenous rituximab in previously untreated Chinese patients with CD20+ diffuse large B-cell lymphoma: a phase II randomized controlled trial”
    • Authors: Gao, Y., Zhang, L., Gao, S., Li, L., Huang, H.
    • Year: 2025
    • Journal: Scientific Reports
    • Volume: 15
    • Issue: 1
    • Page: 100
    • DOI: 10.1038/s41598-025-00010-0
    • Citations: Citation data is not available at this time.
  • “Liposomal mitoxantrone monotherapy in patients with relapsed or refractory mature T-cell and natural killer-cell neoplasms: A phase 2, multicenter, open-label, single-arm trial”
    • Authors: Gao, Y., Huang, Y., Zhang, Q., Yuan, J., Huang, H.
    • Year: 2025
    • Journal: Cancer
    • Volume: 131
    • Issue: 1
    • Page: e35672
    • DOI: 10.1002/cncr.35672
    • Citations: Citation data is not available at this time.
  • “Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B-Cell Lymphoma: A Real-World, Multi-Center, Retrospective Cohort Study”
    • Authors: Zhao, P., Zhao, S., Huang, C., Zhang, Q., Zhang, H.
    • Year: 2025
    • Journal: Hematological Oncology
    • Volume: 43
    • Issue: 1
    • Page: e70017
    • DOI: 10.1002/hon.70017
    • Citations: Citation data is not available at this time.
  • “Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer”
    • Authors: Bardia, A., Hu, X., Dent, R., Patel, G., Curigliano, G.
    • Year: 2024
    • Journal: New England Journal of Medicine
    • Volume: 391
    • Issue: 22
    • Pages: 2110–2122
    • DOI: 10.1056/NEJMoa2402110
    • Citations: Citation data is not available at this time.
  • “Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma: A phase III bridging study in Chinese patients”
    • Authors: Song, Y., Zhang, Q., Cai, Q., Wang, X., Zhu, J.
    • Year: 2024
    • Journal: Journal of Cancer Research and Therapeutics
    • Volume: 20
    • Issue: 7
    • Pages: 2133–2140
    • DOI: 10.4103/jcrt.JCRT_1234_24

 

Stefano Sanduzzi Zamparelli | Medicine and Dentistry | Young Scientist Award

Dr. Stefano Sanduzzi Zamparelli | Medicine and Dentistry | Young Scientist Award

Medico at AORN Cardarelli, Italy

Dr. Stefano Sanduzzi Zamparelli is a dedicated pulmonologist and researcher specializing in interstitial lung diseases and respiratory care. Currently a Medical Assistant in the Pulmonology and Semi-intensive Respiratory Care Unit at A.O.R.N. A. Cardarelli, Naples, he is also pursuing a Ph.D. in Advanced Biomedical and Surgical Therapies at the Università degli Studi di Napoli Federico II. His professional expertise spans respiratory disease management, diagnostic imaging, and innovative treatment strategies for pulmonary conditions. Dr. Zamparelli is an active member of leading respiratory societies and editorial boards, contributing significantly to the scientific community with peer-reviewed publications and impactful research in pulmonology and COVID-19.

Professional Profile

Education

Dr. Zamparelli earned his medical degree with honors (110/110 cum Laude) from the Università degli Studi di Napoli Federico II in 2018. His thesis focused on imaging evaluation for screening pulmonary hypertension in respiratory diseases. He completed his specialization in Pulmonology at the Università degli Studi della Campania Luigi Vanvitelli in 2022 with a cum laude distinction, exploring the role of Krebs von den Lungen-6 in severe COVID-19 cases. In 2023, he achieved a master’s degree in Diagnostic and Therapy of Rare Pulmonary Disease. He is currently engaged in Ph.D. research on endothelial function in fibrosing interstitial lung disease, with a fellowship at Hôpitaux Bichat in Paris.

Professional Experience

Dr. Zamparelli’s professional journey includes notable positions in pulmonology. He served as a Pulmonology Resident at A.O.R.N. V. Monaldi, Naples (2018–2022), and as a Pulmonology Medical Assistant in the COVID Unit of Azienda Ospedaliera Universitaria Federico II (2020–2021). Since 2021, he has been a Medical Assistant at A.O.R.N. A. Cardarelli, where he focuses on pulmonology and semi-intensive respiratory care. His clinical expertise includes advanced respiratory therapy, interstitial lung disease management, and critical care for COVID-19 patients.

Research Interests

Dr. Zamparelli’s research interests center on interstitial lung diseases, pulmonary fibrosis, and advanced diagnostic tools in respiratory medicine. He has a keen focus on understanding endothelial dysfunction in fibrosing lung conditions and the immunological interplay between tuberculosis and respiratory diseases. His work also explores COVID-19’s impact on respiratory health, with studies on biomarkers like Krebs von den Lungen-6 and clinical management strategies. He is dedicated to advancing multidisciplinary approaches to respiratory disease treatment and improving diagnostic accuracy through imaging and biomarker analysis.

Research Skills

Dr. Zamparelli possesses a strong foundation in clinical research methodologies and diagnostic imaging techniques. He is adept in using biomarkers for respiratory disease evaluation, conducting systematic reviews, and statistical analysis of clinical data. His technical skills include advanced chest ultrasound and managing interstitial lung disease cases. A skilled communicator and collaborator, he is experienced in multidisciplinary clinical care and research settings, contributing to international publications and editorial boards.

Awards and Honors

Dr. Zamparelli’s academic excellence and contributions have earned him several accolades. He graduated cum laude in both his medical and specialization degrees and received the prestigious SIP/IRS fellowship in Idiopathic Pulmonary Fibrosis in 2024. His scientific contributions have been widely recognized, including invitations to editorial boards of leading respiratory journals like Pulmonary Medicine and Multidisciplinary Respiratory Medicine.

Conclusion

Dr. Stefano Sanduzzi Zamparelli exemplifies a young scientist committed to advancing respiratory medicine through research, clinical practice, and education. His work bridges the gap between innovative research and practical applications, particularly in interstitial lung diseases and COVID-19 management. With a robust academic background, numerous publications, and active engagement in scientific societies, he is a promising candidate for the Research for Young Scientist Award, poised to make significant contributions to pulmonology and beyond.

Publication Top Notes

  1. The density histograms-derived computerized integrated index (CII) predicts mortality in idiopathic pulmonary fibrosis
    • Authors: Rea, G., Lieto, R., Bruzzese, D., Zamparelli, S.S., Bocchino, M.
    • Year: 2024
  2. Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease
    • Authors: Perrotta, F., Sanduzzi Zamparelli, S., D’Agnano, V., Bianco, A., Mariniello, D.F.
    • Year: 2024
  3. High-Flow Nasal Cannula System in Respiratory Failure Associated with Interstitial Lung Diseases: A Systematic Review and Narrative Synthesis
    • Authors: Pagliaro, R., Aronne, L., Fomez, R., Bianco, A., Perrotta, F.
    • Year: 2024
  4. The Beneficial Impact of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: A Review of the Current Literature
    • Authors: Zamparelli, S.S., Lombardi, C., Candia, C., Bocchino, M., Maniscalco, M.
    • Year: 2024
  5. The Role of SARS-CoV-2 Nucleocapsidic Antigen and Krebs von den Lungen 6 Serum Levels in Predicting COVID-19 Pneumonia Outcome
    • Authors: Sanduzzi Zamparelli, S., Fucci, V., Rea, G., Bocchino, M., Sanduzzi Zamparelli, A.
    • Year: 2024
    • Citations: 1
  6. Targeting Progression in Pulmonary Fibrosis: An Overview of Underlying Mechanisms, Molecular Biomarkers, and Therapeutic Intervention
    • Authors: D’Agnano, V., Mariniello, D.F., Ruotolo, M., Bianco, A., Perrotta, F.
    • Year: 2024
    • Citations: 5
  7. The Unveiled Triad: Clinical, Radiological and Pathological Insights into Hypersensitivity Pneumonitis
    • Authors: Rea, G., Bocchino, M., Lieto, R., Valente, T., Sica, G.
    • Year: 2024
    • Citations: 4
  8. Cardiovascular Risk Associated with Alpha-1 Antitrypsin Deficiency (AATD) Genotypes: A Meta-Analysis with Meta-Regressions
    • Authors: Ambrosino, P., Marcuccio, G., Lombardi, C., Motta, A., Maniscalco, M.
    • Year: 2023
  9. The Evolving Concept of the Multidisciplinary Approach in the Diagnosis and Management of Interstitial Lung Diseases
    • Authors: Sanduzzi Zamparelli, S., Sanduzzi Zamparelli, A., Bocchino, M.
    • Year: 2023
    • Citations: 8
  10. Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients
    • Authors: D’Agnano, V., Scialò, F., Perna, F., Bianco, A., Perrotta, F.
    • Year: 2022
    • Citations: 8

 

 

 

Safayet Jamil | Health Professions | Best Researcher Award

Mr. Safayet Jamil | Health Professions | Best Researcher Award

Lecturer at Frontier University Garowe, Somalia

Safayet Jamil is an emerging professional in the fields of public health and epidemiology, currently contributing as a Lecturer at Frontier University, Garowe, Somalia, and as a Teaching Assistant at Daffodil International University, Bangladesh. With a robust academic background, including ongoing Master’s degrees in Public Health from both Birmingham City University and Daffodil International University, Safayet’s work focuses on global health challenges, epidemiology, and the impact of diseases. His research spans across various public health issues, including infectious diseases, healthcare challenges, and emerging health threats. His contributions are reflected in his significant body of work in renowned journals, which underscores his growing influence in public health discourse. His dedication to health improvement, coupled with his practical experience across different organizations, makes him a promising academic and researcher in the field.

Professional Profile

Education

Safayet Jamil is currently pursuing two Master’s degrees in Public Health (MPH) and Epidemiology, with one at Birmingham City University in the United Kingdom and another at Daffodil International University in Bangladesh. He holds a Bachelor’s degree in Pharmacy from Khwaja Yunus Ali University, Bangladesh, further strengthening his foundation in health sciences. His academic journey is characterized by a keen interest in global health challenges, epidemiology, and research on public health. Through his education, Safayet has cultivated a strong understanding of health systems, disease prevention, and the impact of various health crises on communities.

Professional Experience

Safayet’s professional career is marked by diverse roles in academia and research. As an Adjunct Lecturer at Frontier University, Somalia, he contributes to the Department of Public and Community Health. He also serves as a Teaching Assistant in the Department of Public Health and Development Studies at Daffodil International University, Bangladesh. His practical experience is further enriched by his research involvement at the Centre for Advanced Research and the Centre for Global Migration Studies, where he holds key roles as Senior Research Officer and Research Associate, respectively. He has also gained invaluable experience through internships and roles at the International Center for Diarrhoeal Disease Research, Bangladesh, and Drug International Ltd.

Research Interests

Safayet Jamil’s research interests lie primarily in public health, epidemiology, and global health challenges. His work is particularly focused on understanding the burden of diseases, disaster response, and emerging health threats such as infectious diseases, environmental health, and the healthcare challenges faced by vulnerable populations. He has contributed to significant studies on healthcare access in disaster-prone regions and the epidemiology of diseases such as metapneumovirus, mumps, and Marburg virus. Through his research, Safayet aims to drive evidence-based solutions for health improvement in diverse global settings, including low-resource environments.

Research Skills

Safayet has honed a diverse set of research skills, particularly in epidemiology, public health surveillance, and data analysis. His proficiency extends to analyzing complex health data, conducting field surveys, and assessing public health needs in both urban and rural settings. He is skilled in utilizing advanced research methodologies, including statistical analysis, literature reviews, and data interpretation. His collaborative work on several high-impact publications demonstrates his ability to synthesize data and present findings that influence global health policy and practices. His skills in research are bolstered by his extensive use of academic databases such as Scopus and Google Scholar for staying updated with the latest developments in his field.

Awards and Honors

Although specific awards and honors have not been mentioned in the provided information, Safayet’s contributions to global health research are notable in the academic community. His consistent publication record in respected journals such as The Lancet and Ethics, Medicine and Public Health suggests recognition from his peers. His research on emerging infectious diseases and healthcare challenges has been pivotal in shaping global public health discussions. Given his active role in international research, it is likely that Safayet’s work has contributed to various academic achievements, publications, and collaborations that highlight his standing as an emerging public health expert.

Conclusion

Safayet Jamil is an up-and-coming public health professional whose academic pursuits and research contributions place him at the forefront of addressing global health challenges. With a solid educational background in public health and epidemiology, he has developed a strong foundation in tackling the complexities of global health issues, particularly those faced by underprivileged and disaster-prone populations. His professional experience as a lecturer and researcher across multiple institutions has allowed him to refine his skills in data analysis, research methodology, and health policy. Safayet’s research is poised to have a significant impact, as evidenced by his publication record and ongoing engagement with global health initiatives.

Publication Top Notes

  • Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021
    • Authors: SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, …
    • Journal: The Lancet, 403 (10440), 2204-2256
    • Year: 2024
    • Citations: 149
  • Knowledge, Attitudes, and Practices toward the prevention of COVID-19 in Bangladesh: a systematic review and meta-analysis
    • Authors: A Raquib, R Raquib, S Jamil, A Hossain, F Al-Mamun, MA Mamun
    • Journal: Frontiers in Medicine, 9, 856156
    • Year: 2022
    • Citations: 22
  • Thalassemia prevention: Religious and cultural barriers to premarital screening in Bangladesh
    • Authors: H Suresh, S Jamil, BK Padhi, MJ Hossain
    • Journal: Health Science Reports, 6 (4)
    • Year: 2023
    • Citations: 8
  • Predictors of SARS-CoV-2 vaccine uptake among health professionals: A cross-sectional study in Ghana
    • Authors: AS Mohammed, MN Asumah, BK Padhi, A Sinha, I Mohammed, S Jamil, …
    • Journal: Vaccines, 11 (1), 190
    • Year: 2023
    • Citations: 8
  • Hospital pharmacy practice and drug management system of Khulna division, Bangladesh: results from a cross-sectional study
    • Authors: A Akhter, S Jamil, MJ Hossain, MM Islam, QI Bari, MA Sultana
    • Journal: Bangladesh Pharmaceutical Journal, 25 (1), 44-53
    • Year: 2022
    • Citations: 6
  • Assessment of Academic Resilience and Its Associated Factors Among Pharmacy Students in Twelve Countries
    • Authors: MH Elnaem, WNAAW Salam, AK Thabit, N Mubarak, MM Abou Khatwa, …
    • Journal: American Journal of Pharmaceutical Education, 88 (5), 100693
    • Year: 2024
    • Citations: 5
  • Prevalence and factors associated with musculoskeletal pain among rural handloom weavers in Sirajganj, Bangladesh
    • Authors: S Jamil, MEH Mukul, QI Bari, A Akhter, M Hasan, MM Islam, T Saha, …
    • Journal: Bangladesh Pharmaceutical Journal, 25 (2), 188-198
    • Year: 2022
    • Citations: 5
  • One health implications of bovine leukemia virus seroprevalence: a global systematic review and meta-analysis
    • Authors: G Bushi, SM Vajjala, FB Irfan, D Aggarwal, S Jamil, D Sagar, AK Raju, …
    • Journal: The Evidence, 2 (1)
    • Year: 2024
    • Citations: 4
  • Prevalence and Determinants of Antibiotic Self-Administration Among Adult Antibiotic Users: A Cross-Sectional Study
    • Authors: H Kabir, MK Hasan, AH Tutul, MS Islam, S Jamil, BC Das, MF Islam, …
    • Journal: Patient Preference and Adherence, 2409-2421
    • Year: 2022
    • Citations: 3
  • Water, sanitation, and hygiene (WASH) practices in Africa: exploring the effects on public health and sustainable development plans
    • Authors: OJ Okesanya, G Eshun, BM Ukoaka, E Manirambona, ON Olabode, …
    • Journal: Tropical Medicine and Health, 52 (1), 68
    • Year: 2024
    • Citations: 2

 

Lomanono Ngidie | Nursing and Health Professions | Best Researcher Award

Ms. Lomanono Ngidie | Nursing and Health Professions | Best Researcher Award

Registered Nurse at University of Zambia, Eswatini (Swaziland)

Lomanono Ngidie is a dedicated healthcare professional based in Eswatini, specializing in nursing and public health. With a strong commitment to improving healthcare access, particularly in the field of HIV care, Lomanono has cultivated a rich blend of clinical and academic expertise. She is a registered nurse and a focal person for the Antiretroviral Treatment (ART) department at the AIDS Healthcare Foundation. Her efforts focus on managing ART patients and enhancing the quality of care provided in underserved communities. Lomanono holds a profound belief in the power of education and research to drive change in healthcare practices. A fluent speaker of both SiSwati and English, she is known for her collaborative spirit and ability to work effectively with diverse populations. Lomanono aims to influence healthcare policies and improve patient outcomes through her ongoing research and clinical initiatives.

Professional Profile

Education

Lomanono Ngidie is currently pursuing a Master of Science in Nursing with a specialty in Clinical Nursing at the University of Zambia, expected to be completed in 2024. She previously earned her Bachelor of Nursing Science degree, majoring in Midwifery Science, from the University of Eswatini in 2018. To enhance her practical skills, Lomanono has undertaken various specialized training programs, including NARTIS (Nurse-led ART Initiation), IMAI (Integrated Management of Adult and Adolescent Illnesses), and a comprehensive care package for key populations, all conducted by the Eswatini Ministry of Health. Additionally, she holds a certificate in HIV Testing and Counseling from Population Services International (PSI). Her educational journey reflects her commitment to acquiring knowledge and skills that directly benefit her community, equipping her to address pressing health challenges effectively.

Professional Experience

Lomanono Ngidie has amassed over five years of clinical experience in the nursing field, primarily focusing on HIV care and management. Since 2019, she has served as a registered nurse and ART department focal person at the AIDS Healthcare Foundation in Matsapha, Eswatini. In this role, she manages ART patients, conducts cervical cancer screenings, and provides primary healthcare services. Lomanono previously worked as a registered nurse at the Community Health Intervention Programme (CHIPS), where she honed her clinical skills. Her responsibilities have also included tracking performance benchmarks, report writing, and initiating quality improvement projects aimed at enhancing healthcare delivery. Her extensive experience in community nursing, coupled with her hands-on approach to patient care, positions her as a valuable asset in the healthcare system and demonstrates her commitment to improving health outcomes for vulnerable populations.

Research Interest

Lomanono Ngidie is particularly interested in public health research focusing on HIV care and management. Her current research project investigates the predictors of late presentation for HIV care among adults at the AIDS Healthcare Foundation Clinic in Matsapha, aiming to identify barriers that prevent timely access to treatment. This research is critical, as early initiation of ART significantly improves patient outcomes and reduces transmission rates. Lomanono’s interest extends to exploring strategies for enhancing patient engagement, reducing stigma, and improving healthcare access for marginalized populations. She believes that understanding the sociocultural factors influencing healthcare behavior is vital for developing effective interventions. Her dedication to evidence-based practice drives her research pursuits, as she strives to translate findings into actionable improvements in clinical care and public health policies.

Awards and Honors

While specific awards and honors are not explicitly mentioned in Lomanono Ngidie’s CV, her commitment to excellence in nursing and public health has likely garnered recognition within her professional community. Lomanono’s involvement in quality improvement projects and successful management of ART patients exemplifies her dedication to improving healthcare delivery. Her ongoing research efforts, particularly her manuscript under review in an international journal, reflect her ambition and potential to contribute meaningfully to the field. She is supported by strong references from experienced professionals in healthcare, which further underscores her reputation and capability. As she continues her academic and professional journey, Lomanono is poised to receive recognition for her contributions to nursing and public health in Eswatini and beyond, reflecting her dedication to improving health outcomes for vulnerable populations.

Conclusion

Lomanono Ngidie is a strong candidate for the Best Researcher Award due to her relevant educational background, extensive clinical experience, and a proactive approach to research. Her ongoing work in the field of HIV care is particularly commendable, as it addresses a critical health issue in her community. While there are areas for improvement, such as increasing her publication record and broadening her research experiences, her current achievements and skills position her as a promising researcher with the potential to make significant contributions to the field of nursing and public health. With continued growth and development, Lomanono has the capability to be a leading figure in healthcare research in Eswatini and beyond.

Publication top noted

  • Title: Predictors of late presentation for HIV care among adults at AIDS Healthcare Foundation clinic in Matsapha, Manzini Region, Eswatini 🏥
  • Authors: Lomanono N. Ngidie, Ruth Wahila, Phadaless Sinkamba 👩‍⚕️👩‍⚕️👨‍⚕️
  • Journal: International Journal of Africa Nursing Sciences 📖
  • Year: 2024 🗓️
  • Publication Date: October 2024 📅
  • DOI: 10.1016/j.ijans.2024.100788 🔗

Eranthi Weeratunga | Nursing and Health Professions | Best Researcher Award

Mrs. Eranthi Weeratunga | Nursing and Health Professions | Best Researcher Award

Senior Lecturer, University of Ruhuna, Sri Lanka.

Siyambalapiti Mudalige Eranthi Bimalee Weeratunga is an accomplished Senior Lecturer in the Department of Nursing at the University of Ruhuna, Sri Lanka, with over 14 years of academic experience. She holds an M.Phil. in Health Promotion and has focused her research on psychosocial factors affecting cancer patients’ quality of life, demonstrating her commitment to health promotion and palliative care. Weeratunga has published numerous articles in peer-reviewed journals and presented her findings at both national and international conferences, showcasing her active engagement in the academic community. Additionally, her participation in interdisciplinary collaborations and various university committees reflects her dedication to advancing nursing education and research. With a strong focus on community impact, she aims to improve patient care for vulnerable populations. Overall, her extensive qualifications and contributions make her a highly suitable candidate for the Best Researcher Award, embodying the ideals of excellence in research and education.

Profile:

Education

Eranthi Bimalee Weeratunga has a strong academic background that underpins her expertise in nursing and research. She holds an M.Phil. in Health Promotion from the University of Ruhuna, with her thesis focusing on psychosocial factors associated with the quality of life in cancer patients, reflecting her specialized interest in cancer care and palliative support. She also obtained a B.Sc. (Hons) in Nursing from the Open University of Sri Lanka, where her undergraduate research focused on causes of readmissions following heart valve replacement surgery. Additionally, Eranthi holds a Diploma in Nursing from the School of Nursing in Sri Jayewardenepura. Her commitment to continuous learning is further demonstrated by numerous certifications in critical care, research methodology, and higher education. Eranthi’s diverse educational experiences have equipped her with the knowledge and skills essential for her research and teaching, contributing to her development as a leader in nursing education and cancer care.

Professional Experiences

Siyambalapiti Mudalige Eranthi Bimalee Weeratunga has accumulated extensive professional experience inNursing and academia. After qualifying as a Registered Nurse in 1999, she worked at Sri Jayewardenepura General Hospital, initially in the Otorhinolaryngology department and later in the Cardio-Thoracic Unit for nearly a decade. This clinical exposure provided her with invaluable skills and insights into patient care, particularly in high-pressure environments. Transitioning to academia, she joined the University of Ruhuna as a probationary lecturer, where she has served for over 14 years, contributing to the development of nursing programs and mentoring numerous undergraduate students. Eranthi has also participated in various professional development initiatives, including international training in Sweden, enhancing her expertise in primary health care. Her diverse experiences in clinical practice and education uniquely position her to advance nursing knowledge, particularly in cancer care and palliative support, making her a vital asset to her institution and the broader healthcare community.

Research Skills

Siyambalapiti Mudalige Eranthi Bimalee Weeratunga possesses a robust set of research skills honed through years of academic and professional experience. Her expertise in cancer nursing and palliative care drives her research focus, evidenced by her M.Phil. thesis on psychosocial factors affecting the quality of life in cancer patients. Eranthi is adept at designing and implementing research studies, utilizing both qualitative and quantitative methodologies. She has successfully supervised numerous undergraduate research projects, fostering critical thinking and analytical skills among her students. Her work has been published in peer-reviewed journals and presented at various national and international conferences, showcasing her ability to communicate research findings effectively. Furthermore, Eranthi actively engages in professional development, continuously updating her research methodologies and techniques. Her strong foundation in research not only enhances her own scholarly contributions but also enriches the academic environment for her students and colleagues, making her an asset to the field of nursing.

Award and Recognition

Siyambalapiti Mudalige Eranthi Bimalee Weeratunga has received numerous accolades for her contributions to nursing and research. Her M.Phil. thesis on psychosocial factors affecting the quality of life of cancer patients garnered attention within the academic community, leading to presentations at national and international conferences. Eranthi’s commitment to excellence is reflected in her publications in peer-reviewed journals, showcasing her research findings and innovative approaches to cancer care and health promotion. She has also been recognized for her teaching effectiveness and dedication to mentoring students, earning positive feedback from both peers and students alike. Her involvement in various committees and initiatives further highlights her leadership within the Faculty of Allied Health Sciences. Additionally, her participation in international training programs has enriched her perspective, allowing her to bring global insights to her local context. These accomplishments collectively underscore Eranthi’s significant impact on the nursing field and her potential for future contributions.

Conclusion

Eranthi Bimalee Weeratunga’s extensive academic achievements, impactful research contributions, dedication to teaching, and commitment to professional and community service make her a highly suitable candidate for the Best Researcher Award. Her work in cancer care and health promotion reflects significant contributions to nursing science, underscoring her excellence as a researcher and educator.

Publication Top Notes

  • Psychological distress in cancer patients in Southern province of Sri Lanka
    Authors: EB Weeratunga, C Senadheera, U Ekanayake
    Year: 2016
    Citation: Galle Medical Association, 10.
  • Validation of the Sinhalese Version of Brief COPE Scale for patients with cancer in Sri Lanka
    Authors: E Weeratunga, C Senadheera, M Hettiarachchi, B Perera
    Year: 2022
    Citation: BMC Psychology, 10(157), 1-11.
  • The prevalence and correlates of depressive symptoms in patients with cancer treated in a Tertiary health care facility in Southern Sri Lanka
    Authors: EB Weeratunga, C Senadheera, M Hettiarachchi, B Perera
    Year: 2021
    Citation: International Journal of Multidisciplinary Studies, 8(2), 13-29.
  • Psychosocial Factors Associated with Quality of Life of Patients with Cancer in Southern Sri Lanka
    Authors: E Weeratunga, C Senadheera, M Hettiarachchi, U Ekanayaka, B Perera
    Year: 2019
    Citation: Proceeding of 2nd Annual Research Conference – RuFARS, pp. 30-41.
  • Examining the quality of life of patients living with breast cancer in Southern Sri Lanka: A descriptive cross-sectional study
    Authors: E Weeratunga, C Senadheera, M Hettiarachchi, B Perera
    Year: 2022
    Citation: International Health Trends and Perspective, 2(3), 272-285.
  • Validity and Reliability of the Multi Dimensional Scale of Perceived Social Support (MSPSS) in Cancer Patients
    Authors: EB Weeratunga, C Senadheera, M Hettiarchichi, U Ekanayaka, B Perera
    Year: 2018
    Citation: 11th International Research Conference of General Sir John Kotelawala …
  • Psychological disturbances encountered by selected undergraduates studying at the University of Ruhuna, Sri Lanka during the Covid-19 pandemic: a cross-sectional study
    Authors: THM Kauashani, EB Weeratunga
    Year: 2023
    Citation: Scientific Reports, 2(20559), 1-14.
  • Psychological disturbances encountered by the healthcare professionals, military professionals and general public in Sri Lanka during COVID-19 pandemic: a cross-sectional study
    Authors: TD Sundarapperuma, MWK Gamage, N Rathnayake, EB Weeratunga, …
    Year: 2023
    Citation: BMC Psychiatry, 23(1), 452.
  • Coping Strategies among Patients with Cancer: A Cross-sectional Study done in Teaching Hospital Karapitiya, Southern Sri Lanka
    Authors: EB Weeratunga, C Senadheera, M Hettiarachchi, B Perera
    Year: 2021
    Citation: Proceeding of 4th Annual Research Conference – RuFARS, Faculty of Allied …
  • Satisfaction with cancer care among patients treated in a tertiary care hospital in Southern Sri Lanka
    Authors: EB Weeratunga, C Senadheera, M Hettiarchichi, U Ekanayaka, B Perera
    Year: 2019
    Citation: Asia-Pacific Academic Consortium for Public Health (APACPH), Thailand.
  • Correlates of social support of Breast cancer patients in a tertiary care hospital in Southern Sri Lanka
    Authors: EB Weeratunga, M Hettiarachchi, C Senadheera, U Ekanayaka, B Perera
    Year: 2018
    Citation: Proceedings of International Nursing Congress, Faculty of Allied Health …
  • Quality of life of Breast cancer patients treated at Teaching Hospital Karapitiya, Sri Lanka
    Authors: E Weeratunga, M Hettiarachchi, U Ekanayaka
    Year: 2018
    Citation: University of Ruhuna, Sri Lanka.
  • The depressive symptomatology among cancer patients in a tertiary care hospital in Sri Lanka.
    Authors: EB Weeratunga, B Perera, M Hettiarachchi, C Senadheera, U Ekanayaka
    Year: 2015
    Citation: Ruhunu Clinical Society, Matara, Sri Lanka.
  • The Necessity of Establishing an Advanced Certificate Course in Palliative Care Nursing at the University of Ruhuna, Sri Lanka
    Authors: E Weeratunga, S Karunanayaka, P Kariyawasam, B Wickramarachchi
    Year: 2024
    Citation: International Research Symposium of the Faculty of Allied Health Sciences …
  • Prevalence and Associated Factors of Depressive Symptoms among Informal Caregivers of Patients with Advanced Cancer at the Apeksha Hospital Maharagama, Sri Lanka
    Authors: E Weeratunga, S Goonewardena, L Meegoda
    Year: 2024
    Citation: International Research Symposium of the Faculty of Allied Health Sciences …

 

Ya-Ting Han l Medicine and Dentistry l Best Researcher Award

Dr. Ya-Ting Han l Medicine and Dentistry l Best Researcher Award

Lecturer at Tianjin Medical University, China

Ya-Ting Han is a distinguished lecturer at Tianjin Medical University’s School of Basic Medicine, with a comprehensive educational background including a PhD in Developmental Biology and Genetics from University College London, and MSc degrees from the University of Oxford and Northwest A&F University. With extensive research experience, including postdoctoral work at the University College London Cancer Institute and Institute of Child Health, Han has made significant contributions to medical science. Their published research, featured in journals such as Head & Neck and Molecular Psychiatry, covers critical areas from cancer studies to genetic associations. Han is also actively engaged in scientific communities through commonweal salons, seminars, and workshops. Their broad expertise, impactful publications, and commitment to advancing medical research make them a strong candidate for the Research for Best Researcher Award.

Profile:

Education

Ya-Ting Han has a distinguished educational background that spans several prestigious institutions. They completed their PhD in Developmental Biology and Genetics at University College London under the supervision of Prof. Jane Sowden. Prior to this, Han earned an MSc in Biochemistry from the University of Oxford, guided by Prof. Louis Mahadevan. Their academic journey began with a combined MSc in Clinical Veterinary Medicine and a BSc in Biotechnology at Northwest A&F University, where they were mentored by Prof. Dou Zhongying. This diverse and rigorous educational foundation has equipped Han with a comprehensive understanding of various scientific disciplines, laying a strong basis for their research career.

Professional Experience

Ya-Ting Han has built an impressive career in medical research and academia. Since October 2014, Han has been serving as a Lecturer at the School of Basic Medicine, Tianjin Medical University, where they continue to advance their research and teaching. Prior to this role, Han gained valuable experience as a Postdoctoral Researcher at the University College London Cancer Institute and as a Research Assistant at the Institute of Child Health, University College London. Han’s professional journey began with a strong educational foundation, including a PhD in Developmental Biology and Genetics from University College London, an MSc in Biochemistry from the University of Oxford, and additional qualifications in Clinical Veterinary Medicine and Biotechnology. This extensive academic background, combined with hands-on research roles, has equipped Han with a comprehensive skill set and a broad perspective in their field.

Research Interest

Ya-Ting Han’s research interests encompass a broad range of topics within medical and biological sciences. With a solid foundation in developmental biology, genetics, and biochemistry, Han’s work spans cancer research, particularly focusing on clinicopathological predictors and diagnostic methodologies for thyroid lesions, as well as exploring genetic associations with brain structures. Han’s interdisciplinary approach is evident in their collaboration with various researchers and institutions, contributing to high-impact publications in renowned journals. Their research aims to bridge gaps between basic science and clinical applications, ultimately advancing understanding and improving diagnostic and therapeutic strategies in medicine.

Research Skills

Ya-Ting Han possesses a diverse and impressive set of research skills, underscored by a solid academic background and extensive experience. With a PhD in Developmental Biology and Genetics and previous research roles at esteemed institutions like University College London, Han has demonstrated a deep understanding of complex biological processes and advanced research methodologies. Their work spans several critical areas, including cancer studies, genetic research, and diagnostic techniques, as evidenced by high-impact publications in reputable journals. Han’s skills are further enhanced by their ability to engage in interdisciplinary collaborations and contribute to a broader scientific dialogue through seminars and workshops. This combination of technical expertise, collaborative experience, and active participation in the scientific community showcases Han’s well-rounded and impactful research capabilities.

Award and Recognition

Ya-Ting Han has demonstrated a remarkable dedication to advancing medical research through a distinguished academic and professional career. Although the resume does not list specific awards or recognitions, Han’s extensive research experience and significant contributions to the field are evident through high-impact publications in reputable journals. Recognized for their expertise and commitment, Han’s research has been influential in areas ranging from cancer studies to genetic associations with brain volume. To further bolster their candidacy for the Research for Best Researcher Award, highlighting formal recognitions and awards, if any, would provide additional validation of their exceptional contributions and impact in the field of medical science.

Conclusion

Ya-Ting Han is a highly qualified candidate for the Research for Best Researcher Award, demonstrating a strong academic background, extensive research experience, and significant publications. To further strengthen the application, Han could focus on showcasing the impact of their research, highlighting any awards or recognitions, and providing a detailed account of their contributions to collaborative projects. Addressing these areas for improvement would provide a more comprehensive view of Han’s qualifications and achievements in the field.

Publication Top Notes

  • Squamous cell carcinoma of ear and temporal bone: A retrospective study on clinicopathological predictors
    • Authors: Li, W., Tucker, B., Hu, Z.-D., Zhang, M.-F., Han, Y.-T.
    • Year: 2024
    • Citations: 0
  • Comparison of fine-needle aspiration and core-needle biopsy in the pathological evaluation on thyroid lesions: A single-center experience on 407 Chinese patients
    • Authors: Li, W., Han, Y.-T., Hu, Z., Cai, W., Zhang, M.
    • Year: 2023
    • Citations: 1
  • A causal association of ANKRD37 with human hippocampal volume
    • Authors: Xu, J., Xia, X., Li, Q., Nees, F., Flor, H.
    • Year: 2022
    • Citations: 3
  • Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57CDKN1C and TP53INP1 in mantle cell lymphoma
    • Authors: Li, W., Bi, C., Han, Y., Wang, X., Fu, K.
    • Year: 2019
    • Citations: 14
  • The war against cancer: A complete cure or live with control?
    • Authors: Han, Y., Wang, X.
    • Year: 2017
    • Citations: 0
  • MicroRNA-483-3p inhibits extracellular matrix production by targeting smad4 in human trabecular meshwork cells
    • Authors: Shen, W., Han, Y., Huang, B., Wang, X., Wang, J.
    • Year: 2015
    • Citations: 34

 

Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Dr. Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Ph.D of Beijing institute of Ophalmology, China.

Dr. Xianyang Liu is a distinguished ophthalmology researcher affiliated with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of the renowned uveitis expert Professor Shengping Hou, Dr. Liu has made significant contributions to the field, publishing over 10 SCI articles in prestigious journals like Cellular & Molecular Immunology and Advanced Science. His work, which includes high-impact research on retinal diseases and immune mechanisms, has earned him invitations to present at major international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Dr. Liu’s accolades include the 2023 MCE China Breakthrough Award and recognition as Chongqing Outstanding Student. His expertise spans ophthalmology, immunology, and epigenetics, and his active participation in research projects and academic peer review highlights his commitment to advancing scientific knowledge and excellence in the field.

Profile
Education

Dr. Xianyang Liu, an ophthalmology specialist at the Chongqing Eye Research Institute and Beijing Eye Research Institute, has made significant strides in his field under the mentorship of Professor Shengping Hou. His research has been published in high-impact journals, including Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s work, particularly in basic research and immunology, has garnered international recognition, highlighted by his presentations at the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. His contributions have earned him prestigious awards, such as the 2023 MCE China Breakthrough Award. Dr. Liu’s expertise spans ophthalmology, immunology, and epigenetics, and he has actively participated in various research projects and journal reviews. His career demonstrates a strong commitment to advancing scientific knowledge and a significant impact on his field.

Professional Experience

Dr. Xianyang Liu has a distinguished career in ophthalmology, shaped by his collaboration with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of Professor Shengping Hou, a renowned uveitis expert, Dr. Liu has made significant strides in the field. His professional journey includes publishing over ten high-impact SCI articles in leading journals such as Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s contributions have earned him invitations to present his research at prestigious international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Recognized with multiple awards, such as the 2023 MCE China Breakthrough Award, Dr. Liu has demonstrated his expertise in ophthalmology, immunology, and epigenetics. His role as a reviewer for academic journals further underscores his influence and commitment to advancing scientific knowledge.

Research Interest

Dr. Xianyang Liu’s research interests lie at the intersection of ophthalmology and immunology, with a focus on understanding the molecular mechanisms underlying ocular diseases. His work explores the pathogenesis of uveitis and other retinal conditions through the lens of immune responses and genetic factors. Dr. Liu investigates the role of specific genes and molecular pathways in these diseases, utilizing advanced techniques such as whole-exome sequencing and inflammasome activation studies. His research also delves into epigenetic modifications and their impact on retinal inflammation and neovascularization. By integrating digital medicine and experimental animal models, Dr. Liu aims to uncover novel therapeutic targets and enhance disease management strategies. His contributions are driven by a commitment to advancing knowledge in ophthalmic immunology and improving clinical outcomes for patients with retinal disorders.

Research Skills

Dr. Xianyang Liu possesses a robust set of research skills, underscored by his extensive work in ophthalmology, immunology, and epigenetics. His expertise includes a deep understanding of experimental methodologies and digital medicine, enabling him to conduct high-impact research with significant clinical implications. Proficient in advanced experimental techniques, he excels in the use of complex immunological and genetic assays, contributing to influential studies published in prestigious journals. Dr. Liu’s experience extends to reviewing for top academic journals, reflecting his critical insight into research quality and academic rigor. His ability to integrate basic research with practical applications showcases his versatility and depth of knowledge. Additionally, Dr. Liu’s collaborative skills, demonstrated through multi-author publications, and his involvement in diverse research projects highlight his capacity to work effectively within multidisciplinary teams. Overall, his research skills are marked by precision, innovation, and a commitment to advancing scientific understanding in his field.

 Awards and Recognition

Dr. Xianyang Liu has earned significant accolades and recognition for his contributions to ophthalmology and immunology. In 2023, he was honored with the MCE China Breakthrough Award, a testament to his groundbreaking research. Additionally, he has received prestigious accolades such as the Chongqing Outstanding Student Award, Chongqing Medical University Outstanding Student Award, and the Graduate Science and Technology Innovation Award. His excellence is further highlighted by his invitations to present at renowned conferences, including the 2023 European Human Genetics Conference in Paris and the 2024 China Ophthalmology and Vision Conference, where he was financially supported for his presentation. These awards and recognitions underscore Dr. Liu’s commitment to advancing scientific knowledge and his exceptional contributions to the field of ophthalmology.

Conclusion

Dr. Xianyang Liu is a highly qualified candidate for the Best Researcher Award. His specialization in ophthalmology, substantial publication record in high-impact journals, international recognition, and multiple awards underline his excellence and innovation in research. While there are areas for improvement, such as increasing the broader impact of his work and demonstrating more leadership in research projects, Dr. Liu’s achievements make him a strong contender for this award.

Publications Top Notes

  1. “Icariin alleviates oxygen-induced retinopathy by targeting microglia hexokinase 2”
    • Authors: Li, X., Wang, G., Li, N., Zhou, Q., Hou, S.
    • Journal: Immunology
    • Year: 2024
    • Volume: 173(1)
    • Pages: 141–151
  2. “Autophagy-mediated activation of the AIM2 inflammasome enhances M1 polarization of microglia and exacerbates retinal neovascularization”
    • Authors: Liu, X., Zhou, Q., Meng, J., Mao, L., Hou, S.
    • Journal: MedComm
    • Year: 2024
    • Volume: 5(8)
    • Article Number: e668
  3. “OR11H1 Missense Variant Confers the Susceptibility to Vogt‒Koyanagi‒Harada Disease by Mediating Gadd45g Expression”
    • Authors: Li, X., Wang, G., Wang, X., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2024
    • Volume: 11(11)
    • Article Number: 2306563
  4. “A de novo missense mutation in MPP2 confers an increased risk of Vogt–Koyanagi–Harada disease as shown by trio-based whole-exome sequencing”
    • Authors: Liu, X., Meng, J., Liao, X., Yang, P., Hou, S.
    • Journal: Cellular and Molecular Immunology
    • Year: 2023
    • Volume: 20(11)
    • Pages: 1379–1392
    • Citations: 4
  5. “Integrative Single-Cell Transcriptomics and Epigenomics Mapping of the Fetal Retina Developmental Dynamics”
    • Authors: Li, R., Liu, J., Yi, P., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2023
    • Volume: 10(16)
    • Article Number: 2206623
    • Citations: 2
  6. “Apigenin Alleviates Autoimmune Uveitis by Inhibiting Microglia M1 Pro-Inflammatory Polarization”
    • Authors: Shu, N., Zhang, Z., Wang, X., Zhang, L., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2023
    • Volume: 64(5)
    • Article Number: 21
    • Citations: 8
  7. “NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2-Mediated Pyroptosis Through the Phosphorylated Salt-Inducible Kinase 1/Sterol Regulatory Element Binding Transcription Factor 1 Pathway”
    • Authors: Meng, J., Li, N., Liu, X., Yang, P., Hou, S.
    • Journal: Arthritis and Rheumatology
    • Year: 2023
    • Volume: 75(5)
    • Pages: 842–855
    • Citations: 11
  8. “N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells”
    • Authors: Tang, S., Meng, J., Tan, J., Li, N., Hou, S.
    • Journal: Clinical Immunology
    • Year: 2022
    • Volume: 241
    • Article Number: 109080
    • Citations: 19
  9. “METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m6A-dependent manner”
    • Authors: Meng, J., Liu, X., Tang, S., Li, N., Hou, S.
    • Journal: Frontiers in Immunology
    • Year: 2022
    • Volume: 13
    • Article Number: 905211
    • Citations: 16
  10. “LGALS3BP in Microglia Promotes Retinal Angiogenesis through PI3K/AKT Pathway during Hypoxia”
    • Authors: Zhao, C., Liu, Y., Meng, J., Li, N., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2022
    • Volume: 63(8)
    • Citations: 11